Literature DB >> 30448159

IBS clinical management in Italy: The AIGO survey.

Marco Soncini1, Cristina Stasi2, Paolo Usai Satta3, Giuseppe Milazzo4, Margherita Bianco5, Gioacchino Leandro5, Luigi Maria Montalbano6, Nicola Muscatiello7, Fabio Monica8, Francesca Galeazzi9, Massimo Bellini10.   

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) is the most frequent functional gastrointestinal disorder, both in primary and secondary care. AIMS: (1) To describe diagnostic tools and treatments suggested to IBS patients by Italian gastroenterologists; (2) To evaluate patients' quality of life and psychological involvement and the relationship of these factors with symptom severity.
METHODS: Twenty-six gastroenterologists recorded the demographic and clinical data of 677 IBS patients. Diagnostic and treatment measures taken in the previous year and those suggested by gastroenterologists were analysed.
RESULTS: IBS with constipation was found in 43.4%, with diarrhoea in 21.6%, mixed-IBS in 35.0%. Routine blood tests, ultrasonography, colonoscopy, barium enema and CT were more frequently requested in the previous year than by the gastroenterologists (p < 0.001). Colonoscopy (11%), and ultrasonography (20.4%) were also suggested by the gastroenterologists in a non-negligible number of patients. Abdominal pain and distension, bowel dissatisfaction, anxiety and depression were more severe in females than in males. Quality of life decreased with increasing IBS-symptom severity.
CONCLUSIONS: IBS diagnosis is still largely based on exclusion criteria even if gastroenterologists try to improve diagnostic appropriateness. However, therapy remains symptom-based also in the gastroenterological setting even if gastroenterologists use a wide variety of approaches, including innovative therapies such as linaclotide and psychotherapy.
Copyright © 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diagnosis; Quality of life; Treatment

Mesh:

Substances:

Year:  2018        PMID: 30448159     DOI: 10.1016/j.dld.2018.10.006

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  7 in total

1.  Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity.

Authors:  Laura Prospero; Giuseppe Riezzo; Michele Linsalata; Antonella Orlando; Benedetta D'Attoma; Marta Di Masi; Manuela Martulli; Francesco Russo
Journal:  BMC Gastroenterol       Date:  2021-05-22       Impact factor: 3.067

Review 2.  Gastrointestinal Ultrasound in Functional Disorders of the Gastrointestinal Tract - EFSUMB Consensus Statement.

Authors:  Giovanni Maconi; Trygve Hausken; Christoph F Dietrich; Nadia Pallotta; Ioan Sporea; Dieter Nurnberg; Klaus Dirks; Laura Romanini; Carla Serra; Barbara Braden; Zeno Sparchez; Odd Helge Gilja
Journal:  Ultrasound Int Open       Date:  2021-05-28

3.  Irritable Bowel Syndrome and Gluten-Related Disorders.

Authors:  Paolo Usai-Satta; Gabrio Bassotti; Massimo Bellini; Francesco Oppia; Mariantonia Lai; Francesco Cabras
Journal:  Nutrients       Date:  2020-04-17       Impact factor: 5.717

Review 4.  Low Fermentable Oligo- Di- and Mono-Saccharides and Polyols (FODMAPs) or Gluten Free Diet: What Is Best for Irritable Bowel Syndrome?

Authors:  Massimo Bellini; Sara Tonarelli; Maria Gloria Mumolo; Francesco Bronzini; Andrea Pancetti; Lorenzo Bertani; Francesco Costa; Angelo Ricchiuti; Nicola de Bortoli; Santino Marchi; Alessandra Rossi
Journal:  Nutrients       Date:  2020-11-01       Impact factor: 5.717

5.  Irritable Bowel Syndrome: A Multifaceted World Still to Discover.

Authors:  Gabrio Bassotti
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

6.  A Low-FODMAP Diet for Irritable Bowel Syndrome: Some Answers to the Doubts from a Long-Term Follow-Up.

Authors:  Massimo Bellini; Sara Tonarelli; Federico Barracca; Riccardo Morganti; Andrea Pancetti; Lorenzo Bertani; Nicola de Bortoli; Francesco Costa; Marta Mosca; Santino Marchi; Alessandra Rossi
Journal:  Nutrients       Date:  2020-08-07       Impact factor: 5.717

Review 7.  Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.

Authors:  Eric D Shah; Brian E Lacy; William D Chey; Lin Chang; Darren M Brenner
Journal:  Am J Gastroenterol       Date:  2021-08-01       Impact factor: 12.045

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.